The source of comparative advantage in the biotechnology industry: A real options approach
β Scribed by Brian F. Lavoie; Ian M. Sheldon
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 40 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0742-4477
No coin nor oath required. For personal study only.
β¦ Synopsis
Sources of heterogeneity within the process of research and development (R&D) investment, such as international differences in the maximum per-period rate of investment and level of regulatory uncertainty, offer a plausible explanation for US comparative advantage in biotechnology. Using dynamic stochastic simulation, the results presented in this article suggest US biotechnology firms may initiate more R&D projects, innovate earlier and more rapidly, persevere longer in the face of mounting R&D costs, and successfully complete more R&D projects than European firms [Econ-Lit citations: F100, O310, O330].
π SIMILAR VOLUMES
## Abstract Background electrolytes (BGEs) prepared in pure organic solvents are common alternatives to aqueous BGEs in capillary electrophoresis. Several general advantages of organic solvents over water have been asserted in the literature, namely (i) organic solvents increase the separation sele
This article analyses the sources of technological change in the Spanish food and drink industry (F&DI). The increasing importance of technical change has called for a better understanding of the innovation process and sources of technical advances in particular. The article examines the generally a
## Abstract This paper assesses valuation methods of income producing real estate used by real estate appraisers from the perspective of commercial property lenders. Imbedded in any valuation are assumptions made about income growth and property price appreciation. These assumptions are evaluated h